Ocular Therapeutix™ Achieves Target Randomization of 555 Subjects in SOL-R
Go back to Ocular Therapeutix™ Achieves Target Randomization of 555 Subjects in SOL-R| (NASDAQ: OCUL) | Delayed: 10.59 +0.55 (5.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.04 | 52 Week High | $14.50 | |||
| Open | $10.83 | 52 Week Low | $4.04 | |||
| Day High | $11.20 | P/E | N/A | |||
| Day Low | $10.50 | EPS | $0.00 | |||
| Volume | 8,286,711 | |||||
